Morningstar® Stock Report™

Novo Nordisk A/S NOVO B

Letzte Unternehmensnews

DatumZeitQuelleTitel
Previous Stories...
17.05.202414:20NASDAQNEWSNovo Nordisk A/S - share repurchase programme
17.05.202414:20DJNMPress Release: Novo Nordisk A/S - share repurchase programme
17.05.202410:43DJNMDJ Dow Hitting 40,000 Is Good but Look Here for -2-
17.05.202410:43DJNMDJ Dow Hitting 40,000 Is Good but Look Here for Where Markets Are Headed, and 5 Other Things to Know Today. -- Barrons.com
16.05.202416:02DJNMDJ Novo Nordisk A/S Stock Falls Thursday, Underperforms Market
16.05.202414:47DJNMDJ Fire at Novo Nordisk Construction Site Gives Investors A Scare -- WSJ
16.05.202414:08DJNMDJ Roche's New Weight-Loss Data Shows Lilly Isn't Unbeatable in Obesity -- Barrons.com
16.05.202413:21DJNMNovo Nordisk Construction Site Hit by Fire
16.05.202413:06DJNMDJ Novo Nordisk Construction Site Hit by Fire
15.05.202416:02DJNMDJ Novo Nordisk A/S Stock Rises Wednesday, Outperforms Market
15.05.202411:23NASDAQNEWSNovo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
15.05.202411:23DJNMPress Release: Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
14.05.202420:22DJNMDJ Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs -- WSJ
14.05.202416:02DJNMDJ Novo Nordisk A/S Stock Falls Tuesday, Underperforms Market
13.05.202416:02DJNMDJ Novo Nordisk A/S Stock Rises Monday, Outperforms Market
13.05.202415:49NASDAQNEWSNovo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial
13.05.202415:49DJNMPress Release: Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial
13.05.202414:31DJNMDJ Moody's Ratings Assigns A1 Rating To Novo Nordisk's New Notes; Outlook Positive
13.05.202411:15DJNMDJ Novo Nordisk's Wegovy Supply is Ramping Up -- Market Talk
10.05.202406:32DJNMDJ Stocks: Stock Bets Tied to Weight Drugs Prove Tricky -- WSJ